Publications by authors named "Andrew J Coldman"

Claim this Profile
T
The OncoSim-Breast Cancer Microsimulation Model.
Jean H E Yong, Claude Nadeau, William M Flanagan, Andrew J Coldman, Keiko Asakawa

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results.
Laurie W Smith, C Sarai Racey, Lovedeep Gondara, Mel Krajden, Marette Lee, Andrew J Coldman

BMJ Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
Ian Cromwell, Laurie W Smith, Kim van der Hoek, Lindsay Hedden, Andrew J Coldman

Cancer Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.
Andrew J Coldman, Dirk van Niekerk, Mel Krajden, Laurie W Smith, Darrel Cook

Int J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
Darrel A Cook, Mel Krajden, Adam R Brentnall, Lovedeep Gondara, Tracy Chan, Andrew J Coldman

Int J Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.
Darrel A Cook, Laurie W Smith, Jennifer H Law, Wendy Mei, Lovedeep Gondara, Andrew J Coldman

J Clin Virol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Gina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, Laurie W Smith, Darrel Cook, Andrew J Coldman

JAMA· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer in First Nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010.
Colleen E McGahan, Kevin Linn, Preston Guno, Harmony Johnson, Andrew J Coldman

Cancer Causes Control· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience.
Kathy M Ceballos, Marette Lee, Darrel A Cook, Laurie W Smith, Lovedeep Gondara, Andrew J Coldman

J Low Genit Tract Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptima HPV Assay versus Hybrid Capture 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
Darrel A Cook, Laurie W Smith, Jennifer Law, Wendy Mei, Dirk J van Niekerk, Andrew J Coldman

J Clin Virol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Gina S Ogilvie, Mel Krajden, Dirk van Niekerk, Laurie W Smith, Darrel Cook, Andrew J Coldman

Int J Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.
Andrew J Coldman, Lovedeep Gondara, Laurie W Smith, Dirk van Niekerk, Kathy Ceballos

Br J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Gina S Ogilvie, Laurie W Smith, Dirk van Niekerk, Fareeza Khurshed, Heather N Pedersen, Andrew J Coldman

BMC Public Health· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
Darrel A Cook, Wendy Mei, Laurie W Smith, Dirk J van Niekerk, Kathy Ceballos, Andrew J Coldman

BMC Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.
Gina S Ogilvie, Monika Naus, Deborah M Money, Simon R Dobson, Dianne Miller, Andrew J Coldman

Int J Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
Andrew J Coldman, Norm Phillips, Dirk van Niekerk, Laurie Smith, Mel Krajden

J Obstet Gynaecol Can· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Reka Pataky, Zahra Ismail, Andrew J Coldman, Mark Elwood, Karen Gelmon

J Med Screen· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Laurie W Smith, Fareeza Khurshed, Dirk J van Niekerk, Mel Krajden, Sandra B Greene, Andrew J Coldman

BMC Public Health· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.
Reka Pataky, Roman Gulati, Ruth Etzioni, Peter Black, Kim N Chi, Andrew J Coldman

Int J Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Gina S Ogilvie, Laurie W Smith, Dirk J van Niekerk, Fareeza Khurshed, Mel Krajden, Andrew J Coldman

Int J Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
Christina R Weisstock, Rasika Rajapakshe, Christabelle Bitgood, Steven McAvoy, Paula B Gordon, Andrew J Coldman

Cancer Prev Res (Phila)· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
Reka Pataky, Linlea Armstrong, Stephen Chia, Andrew J Coldman, Charmaine Kim-Sing

BMC Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive screening mammograms and biopsies among women participating in a Canadian provincial breast screening program.
Andrew J Coldman, Norm Phillips

Can J Public Health· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial).
Gina S Ogilvie, Dirk J van Niekerk, Mel Krajden, Ruth E Martin, Thomas G Ehlen, Andrew J Coldman

BMC Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
Andrew J Coldman, Norm Phillips, Ivo A Olivotto, Paula Gordon, Linda Warren

J Med Screen· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis